◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CGEN

Compugen Ltd. (CGEN) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-16

Compugen Ltd. (CGEN) operates in the Biotechnology industry and is headquartered in Holon, Israel with about 75 employees. Its market capitalization is roughly $223 million. In the fiscal year ended 2025-12-31, CGEN reported $73M in revenue and $35M in net income.

Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Interactive charts & full statements → Open the CGEN valuation workbench →

CGEN Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$73M$28M$34M$8M
Gross Profit$64M$20M$32M$6M
Operating Income (EBIT)$31M($15M)($13M)($35M)
Net Income$35M($14M)($19M)($34M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CGEN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$2M$67M$2M$1M$2M
Gross Profit$0M$64M$0M($0M)($0M)
Operating Income (EBIT)($9M)$56M($8M)($8M)($8M)
Net Income($8M)$57M($7M)($7M)($7M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CGEN Free Cash Flow History

CGEN Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$157M$115M$121M$94M
Total Liabilities$54M$60M$56M$16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CGEN viewer.

Other Companies in Biotechnology

← CGEMAll stocksCGNT →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.